Literature DB >> 18463503

Nurr1 transcriptionally regulates the expression of alpha-synuclein.

Yan Xiang Yang1, David S Latchman.   

Abstract

Parkinson's disease is one of the most common neurodegenerative disorders and still remains incurable. The condition is linked to mutations and alterations in expression in several genes, in particular that encoding alpha-synuclein. Mutations in Nurr1 leading to a reduction in expression were also found to lead to Parkinson's disease. In view of the importance of gene regulation in Parkinson's disease, we examined the effect of changes in Nurr1 expression on alpha-synuclein expression. Nurr1 was shown to be involved in the regulation of alpha-synuclein, as decreased expression of Nurr1, which has been found in Parkinson's disease patients with Nurr1 mutations, was shown to transcriptionally increase alpha-synuclein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463503     DOI: 10.1097/WNR.0b013e3282ffda48

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

1.  Proteasomal inhibition as a treatment strategy for Parkinson's disease: the impact of α-synuclein on Nurr1.

Authors:  Michael J Devine
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

2.  Activation of Peroxisome Proliferator-Activated Receptor-α Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons.

Authors:  Carl G Gottschalk; Avik Roy; Malabendu Jana; Madhuchhanda Kundu; Kalipada Pahan
Journal:  Mol Neurobiol       Date:  2019-05-24       Impact factor: 5.590

Review 3.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

4.  Nurr1 protein is required for N-methyl-D-aspartic acid (NMDA) receptor-mediated neuronal survival.

Authors:  Bruna Barneda-Zahonero; Joan-Marc Servitja; Nahuai Badiola; Alfredo J Miñano-Molina; Rut Fadó; Carlos A Saura; José Rodríguez-Alvarez
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 5.  α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson; Paramita Chakrabarty
Journal:  Acta Neuropathol       Date:  2019-02-23       Impact factor: 17.088

6.  Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

Authors:  Lifen Zhang; Weidong Le; Wenjie Xie; John A Dani
Journal:  Neurobiol Aging       Date:  2011-04-30       Impact factor: 4.673

Review 7.  Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.

Authors:  Ronglin Wang; Shaosong Yang; Tiejian Nie; Gang Zhu; Dayun Feng; Qian Yang
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

8.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

9.  In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility.

Authors:  Vivek K Unni; Tamily A Weissman; Edward Rockenstein; Eliezer Masliah; Pamela J McLean; Bradley T Hyman
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

10.  Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.

Authors:  Maria Angeliki S Pavlou; Nicoló Colombo; Sandra Fuertes-Alvarez; Sarah Nicklas; Laura Gonzalez Cano; Maria C Marín; Jorge Goncalves; Jens C Schwamborn
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.